171 related articles for article (PubMed ID: 34327896)
21. Antibody producing human-human hybridomas. I. Technical aspects.
Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
[TBL] [Abstract][Full Text] [Related]
22. Extensive loss of human DNA accompanies loss of antibody production in heteromyeloma hybridoma cells.
Koropatnick J; Pearson J; Harris JF
Mol Biol Med; 1988 Apr; 5(2):69-83. PubMed ID: 3260988
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies to Treponema pallidum.
van de Donk HJ; van Embden JD; de Jong A; van Olderen MF; Osterhaus AD
Dev Biol Stand; 1984; 57():107-11. PubMed ID: 6396126
[TBL] [Abstract][Full Text] [Related]
24. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
25. Development of mouse hybridomas by fusion of myeloma cells with lymphocytes derived from spleen, lymph node, and bone marrow.
Başalp A; Yücel F
Hybrid Hybridomics; 2003 Oct; 22(5):329-31. PubMed ID: 14678651
[TBL] [Abstract][Full Text] [Related]
26. Development of a rapid microELISA assay for screening hybridoma supernatants for murine monoclonal antibodies.
Handley HH; Glassy MC; Cleveland PH; Royston I
J Immunol Methods; 1982 Nov; 54(3):291-6. PubMed ID: 6983543
[TBL] [Abstract][Full Text] [Related]
27. A human-mouse hybridoma which secretes monoclonal thyroglobulin autoantibody with properties similar to those of the donor patient's serum autoantibody.
Petersen VB; Fukuma N; McLachlan SM; Bradbury J; Beever K; Devey ME; Bleasdale-Barr KM; Phillips DI; Baylis P; Ryley H
Autoimmunity; 1989; 4(1-2):89-102. PubMed ID: 2562381
[TBL] [Abstract][Full Text] [Related]
28. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
[TBL] [Abstract][Full Text] [Related]
29. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology.
Brams P; Pettijohn DE; Brown M; Olsson L
J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806
[TBL] [Abstract][Full Text] [Related]
30. Development of a quantitative cell-based intracellular ELISA for the screening of B cell hybridoma supernatants: a novel rapid assay to detect positive clones.
Renukaradhya JG; Sriram V; Polakova K; Russ G; Brutkiewicz RR
Hybrid Hybridomics; 2004 Dec; 23(6):373-9. PubMed ID: 15684665
[TBL] [Abstract][Full Text] [Related]
31. The use of an anti-CD40 agonist monoclonal antibody during immunizations enhances hybridoma generation.
Rycyzyn MA; Staquet K; Fisher J; Bannish G; Bassiri A; Duchala C; Giles-Komar J
Hybridoma (Larchmt); 2008 Feb; 27(1):25-30. PubMed ID: 18294073
[TBL] [Abstract][Full Text] [Related]
32. Optimization of stereospecific targeting technique for selective production of monoclonal antibodies against native ephrin type-A receptor 2.
Yamasaki Y; Miyamae C; Isozaki Y; Ichikawa K; Kaneko Y; Oda Y; Murayama T; Sakurai T; Tamai K; Tsumoto K; Tomita M
J Immunol Methods; 2020; 484-485():112813. PubMed ID: 32592774
[TBL] [Abstract][Full Text] [Related]
33. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
Salgar SK; Paape MJ; Alston-Mills B
Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
[TBL] [Abstract][Full Text] [Related]
34. A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line.
Listek M; Hönow A; Gossen M; Hanack K
Sci Rep; 2020 Feb; 10(1):1664. PubMed ID: 32015441
[TBL] [Abstract][Full Text] [Related]
35. Hybridoma technology for the generation of monoclonal antibodies.
Zhang C
Methods Mol Biol; 2012; 901():117-35. PubMed ID: 22723097
[TBL] [Abstract][Full Text] [Related]
36. Comparison of techniques to screen and characterize bacteria-specific hybridomas for high-quality monoclonal antibodies selection.
Charlermroj R; Oplatowska M; Kumpoosiri M; Himananto O; Gajanandana O; Elliott CT; Karoonuthaisiri N
Anal Biochem; 2012 Feb; 421(1):26-36. PubMed ID: 22033288
[TBL] [Abstract][Full Text] [Related]
37. Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual.
Lane HC; Shelhamer JH; Mostowski HS; Fauci AS
J Exp Med; 1982 Jan; 155(1):333-8. PubMed ID: 6976416
[TBL] [Abstract][Full Text] [Related]
38. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.
Smith SA; Crowe JE
Microbiol Spectr; 2015 Feb; 3(1):AID-0027-2014. PubMed ID: 26104564
[TBL] [Abstract][Full Text] [Related]
39. [Progress in preparation of small monoclonal antibodies of knock out technique].
Liu J; Mao XM; Li LL; Li XX; Wang Y; Lan Y
Zhongguo Zhong Yao Za Zhi; 2015 Oct; 40(19):3737-41. PubMed ID: 26975094
[TBL] [Abstract][Full Text] [Related]
40. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.
Yang LJ; Wang WL
World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
